Neuroimmunology
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
Aug. 15, 2024
Anastasia Zekeridou MD PhD
Senior Associate Consultant, Division of Clinical Biochemistry & Immunology
Department of Laboratory Medicine and Pathology
Senior Associate Consultant, Department of Neurology
Assistant Professor of Laboratory Medicine and Pathology
Assistant Professor of Neurology
Mayo Clinic
Rochester, Minnesota
Contributor Disclosures
Dr. Zekeridou of Mayo Clinic has a patent pending on the use of PDE10A-IgG as a biomarker of paraneoplastic autoimmunity.